Mondher Mahjoubi

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 433 citations

Medicine, Oncology, Pharmacology +14

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.

Faouzi Saliba, R. Hagipantelli, J. L. Misset et al. · Journal of Clinical Oncology · 1998 · 142 citations

Medicine, Oncology, Pharmacology +17

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics

Ernesto Wasserman, C. Cuvier, François Lokiec et al. · Journal of Clinical Oncology · 1999 · 134 citations

Medicine, Oncology, Pharmacology +17

Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice

Sylvie M. Guichard, Étienne Chatelut, Isabelle Lochon et al. · Cancer Chemotherapy and Pharmacology · 1998 · 71 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Circadian Rhythm of Irinotecan Tolerability in Mice

Elisabeth Filipski, G Lemaigre, Xuhui Liu et al. · Chronobiology International · 2004 · 36 citations

Medicine, Oncology, Pharmacology +15